Trial Profile
A multicenter, randomized, parallel-groups, double-blind placebo-controlled study comparing the efficacy, safety, and tolerability of administration of ezetimibe/simvastatin tablet 10/20 mg versus doubling the dose of simvastatin 20 mg [simvastatin 40 mg] in subjects with primary hypercholesterolemia and coronary heart disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Feb 2022
Price :
$35
*
At a glance
- Drugs Ezetimibe/simvastatin (Primary) ; Simvastatin
- Indications Coronary disorders; Hypercholesterolaemia
- Focus Therapeutic Use
- Sponsors Organon
- 01 Jun 2008 Status changed from in progress to completed.
- 21 Mar 2008 Status changed from recruiting to in progress, as reported by ClinicalTrials.gov.
- 10 Feb 2007 New trial record.